Evidence map›Paper›PMID 20462604›Full record

ArticleThe Journal of surgical research2011

Role of COX-2 in tumorospheres derived from a breast cancer cell line.

Balraj Singh, Kendra R Cook, Laura Vincent, Carolyn S Hall, Cecilia Martin, Anthony Lucci

Abstract read
In one paragraph

Article in The Journal of surgical research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Balraj SinghDepartment of Surgical Oncology and Advanced Research Center for Microscopic Disease, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
Kendra R Cook
Laura Vincent
Carolyn S Hall
Cecilia Martin
Anthony Lucci
The University of Texas MD Anderson Cancer Center · USSociety of Surgical Oncology · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Role of COX-2 in breast cancer metastasis to boneR21DK067682 · NIDDK · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI LUCCI, ANTHONY · 2003 to 2004
$302k
NCI NIH HHS CA16672NCI NIH HHS P30 CA016672NIDDK NIH HHS R21 DK067682
6 · The paper itself

Abstract

backgroundCyclooxygenase-2 (COX-2) expression in primary breast cancer predicts tumor cell dissemination to bone marrow, which is a risk factor for recurrence and distant metastasis. "Stem-like" phenotype may be important in cancer metastasis.

methodsTo investigate the role of COX-2 protein in breast cancer stem-like cells, we analyzed it by co-immunofluorescence in tumorospheres derived from the MCF7 estrogen receptor-positive breast cancer cell line. To evaluate COX-2 function we utilized a COX-2 inhibitor in a clonogenicity assay performed with tumorospheres-derived cells.

resultsWe detected rare cells in tumorospheres (one cell per tumorosphere) with very high COX-2 expression (COX-2(high)). COX-2 transfected MCF7 cells were able to generate long-term tumorospheres culture, even though transfection efficiency was only one in a million cells. We detected expression of OCT4 in some COX-2(high) cells, supporting the hypothesis that these cells could be cancer stem-like cells. It is important that COX-2(high) cells showed less expression of Ki-67 than did neighboring cells, indicating that COX-2(high) cells may be progenitors of tumorospheres. Celecoxib inhibited the growth of tumorosphere cultures and the ability of tumorosphere-derived cells to form colonies in vitro, indicating an active role of COX-2 in these processes. However, 2 μM celecoxib failed to eradicate tumorosphere-initiating cells. Finally, we detected rare COX-2(high) cells among SUM149 inflammatory breast cancer cells growing on plastic in serum-containing medium; the SUM149 cell line produces a very high level of COX-2 protein.

conclusionOur results support a role for COX-2 in stem-like breast cancer cells and suggest a mechanism behind a role for COX-2 in disseminated tumor cells, which are known to exhibit characteristic biomarkers and functional properties of stem-like cells.

Indexed as

Breast NeoplasmsCelecoxibCell Line, TumorCell ProliferationCyclooxygenase 2Cyclooxygenase 2 InhibitorsFemaleHumansNeoplasm MetastasisNeoplastic Stem CellsOctamer Transcription Factor-3PyrazolesReceptors, EstrogenSulfonamidesCelecoxibCyclooxygenase 2Cyclooxygenase 2 InhibitorsOctamer Transcription Factor-3POU5F1 protein, humanPyrazolesReceptors, EstrogenSulfonamides

Identifiers

PMID20462604
PMCPMC2921551
OpenAlexW2104583717

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.